Genotype-guided Treatment in Newly Diagnosed PTCL

Clinical trial NCT05675813 · RECRUITING

Trial details

NCT number: NCT05675813
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2023-02-13
Primary completion: 2026-07-15
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.